Oaktree Acquisition Corp. II

Venture Capital

Oaktree Acquisition Corp. II is a Venture Capital firm based in Los Angeles, United States.

SPAC sponsored by Oaktree Capital Management that raised $250M in a Sept 2020 IPO and merged with Alvotech, an Icelandic biosimilars company, in a $2.28B deal announced Dec 2021.

Late Stage
Public
Healthcare
Industrials
Life Sciences
Website
Headquarters
Los Angeles, United States
Founded
2020
Portfolio Companies
2
Recorded investments
3
Latest recorded investment
Dec 2021
Geographic Focus
Global, United States
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/oaktree-acquisition-corp-ii?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 2 portfolio companies and 3 funding rounds for this investor. to use credits for reveals, or explore the API.

Investment Thesis

Blank-check SPAC formed to acquire a high-quality growth business; completed merger with Alvotech (biosimilars) in 2022.

It was founded in 2020. Indexed has recorded 3 investments for Oaktree Acquisition Corp. II. Its portfolio includes Alvotech and Hims and Hers. Focus areas include Healthcare and Industrials.

Portfolio2

Co-investors24

Sign up to view co-investors

Up to 24 co-investors shown

Venture Capital ×17 · Private Equity ×3 · Hedge Fund ×2

Recorded investments3

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Oaktree Acquisition Corp. II on Indexed.vc
<a href="https://indexed.vc/investors/oaktree-acquisition-corp-ii"><img src="https://indexed.vc/api/badge/investor/oaktree-acquisition-corp-ii" alt="Oaktree Acquisition Corp. II on Indexed.vc" width="260" height="76" /></a>